Papers
1
Total Citations
17
H-Index
1
About
Bo Ma is a biomedical engineer and microfluidics researcher whose work sits at the critical intersection of infectious disease diagnostics and automated clinical systems. His most notable contribution is the development of CAST-R, a rapid and automated antimicrobial susceptibility testing platform designed to combat the growing threat of multidrug-resistant pathogens. Published in 2022 and already accumulating 17 citations, this work addresses a pressing clinical challenge: traditional susceptibility testing is often too slow and labor-intensive to guide timely treatment decisions in life-threatening conditions like sepsis. By engineering a system capable of delivering reliable results directly from positive blood cultures, Ma's research has the potential to meaningfully accelerate the path from diagnosis to targeted therapy, reducing both patient mortality and the misuse of broad-spectrum antibiotics. His focus on automation and clinical translation reflects a broader commitment to making advanced diagnostic tools accessible and practical in real-world healthcare settings. For students and researchers working in point-of-care diagnostics, antimicrobial resistance, or lab-on-a-chip technologies, Bo Ma's work represents a compelling model of engineering innovation applied to urgent global health priorities.
Research Focus
Key Achievements
Top Papers
- 1